Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Medicinal Chemistry|October 11, 2025
Leveraging Peripheral CB1 Antagonism in 1,4,5,6-Tetrahydropyridazine-Based Amidine Substituted Sulfonyl Analogs for Treating Metabolic DisordersPinaki Bhattacharjee, Szabolcs Dvorácskó, Paul Volesky, et al.Journal of Biomolecular Structure & Dynamics|January 19, 2022
Virtual screening of natural products inspired in-house library to discover potential lead molecules against the SARS-CoV-2 main proteaseAakriti Garg, Narender Goel, Nipun Abhinav, et al.Metabolism: Clinical and Experimental|May 14, 2025
Evaluation of tetrahydropyridazine-based peripherally restricted dual inhibitors of CB1R and inducible nitric oxide synthase (iNOS) for treating metabolic syndrome disordersPinaki Bhattacharjee, Szabolcs Dvorácskó, Océane Pointeau, et al.Molecular Psychiatry|December 11, 2025
Brain CB2 receptor: a new target in medication development for treating opioid use disorder in rodentsOmar Soler-Cedeño, Hai-Ying Zhang, Emma Xiong, et al.Journal of Medicinal Chemistry|August 23, 2023
Cannabinoformins: Designing Biguanide-Embedded, Orally Available, Peripherally Selective Cannabinoid-1 Receptor Antagonists for Metabolic Syndrome DisordersSzabolcs Dvorácskó, Alexa Herrerias, Anna Oliverio, et al.Experimental Parasitology|March 21, 2021
Furan derivatives impair proliferation and affect ultrastructural organization of Trypanosoma cruzi and Leishmania amazonensisAline Araujo Zuma, Sara Teixeira de Macedo-Silva, Anushree Achari, et al.Pageof 2